In dysbetalipoproteinemia (formerly Type 3 hyperlipoproteinemia), patients carry a further ApoE2 homozygosity or a rare binding-defective dominant mutation in ApoE, leading to impaired hepatic clearance of remnant lipoproteins. Here, APOE is linked to hyperlipoproteinemia type 3.